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The Death Knoll for the MMSE:
Has It Outlived Its Purpose?
Ruth E. Nieuwenhuis-Mark, PhD1
Abstract
The Mini-Mental State Examination (MMSE) is arguably the best-known cognitive screen in the world. Originally designed to assess
cognitive impairment in elderly populations, it has become one of the first steps toward a dementia diagnosis. Routinely used in
the clinic and in research internationally, the MMSE, despite its flaws, has managed to retain its popularity for more than 30 years.
This review explores when and how the test is used, lists its advantages and disadvantages, and ultimately questions its value. The
specific issue that is addressed here is whether the test has outlived its original purpose. The conclusion is that although the MMSE
may be a useful tool in many circumstances where a cognitive screen is required, practitioners should be wary of using MMSE total
scores as a shortcut toward a dementia diagnosis.
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The Mini-Mental State Examination (MMSE) first appeared 34
years ago1 and since then it has become arguably the most well
known and used short cognitive screening instrument.2-4
Indeed, development of the MMSE-II is currently underway.
A few reviews have appeared over the years assessing the test’s
merits but most have appeared in other languages than Eng-
lish.5,6 The best-known English-language review appeared
back in 1992,7 while Mitchell8 recently conducted a meta-
analysis, the first attempt to quantify the test’s validity over
populations, testers, studies, and settings. The focus of the cur-
rent review is 3-fold: (a) to examine whether the MMSE has
fulfilled its original purpose, (b) to compare its advantages and
disadvantages in a clear way, and (c) to stimulate the debate as
to whether an MMSE total score should ever be used in the
absence of more detailed assessment by clinicians attempting
to make a dementia diagnosis.
The Original Purpose of the MMSE
The test was developed in the 1970s by 2 young physicians
(Marshall Folstein and his wife Susan) working under the men-
torship of Paul McHugh.9 Susan would report daily on the men-
tal state of the geriatric patients at Cornell Medical Center’s
Westchester Hospital and Marshall would typically ask how
she would know whether someone was doing ‘‘better’’ or
‘‘worse.’’ Susan finally asked him to write down the questions
he wanted her to ask the patients. He did and the MMSE was
born, at the time a truly innovative tool for assessing cognitive
functioning in an elderly hospitalized population. The 5- to
10-minute screen was given the name ‘‘Mini’’ because it only
assessed aspects of cognitive functioning, ignoring among
other things, mood. The authors believed that it thoroughly
measured cognition, that it could be used for repeated testing,
and that it could differentiate between patients with and with-
out cognitive disturbance. They made these claims after asses-
sing a total of only 206 patients with a wide range of disorders
compared to a group of 63 healthy, age-matched controls.1
Item Structure of the Original MMSE
The original test is untimed and includes 11 questions divided
into 2 sections. The first measures orientation (to time and
place), memory and attention and verbal responses are
required. The second section measures the ability to name, to
follow commands (verbal and written), the ability to sponta-
neously write a sentence and, finally, to copy a relatively com-
plex figure (two interlocking pentagons). The total score
possible for the test is 30. Ramirez et al10 found that the Flesch
Reading Ease Index was 86.4 for the English MMSE and
the Flesch-Kincaid grade level was 2.9. This suggests that it
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is easy to understand by everyone at US second grade reading
level and above making its use among various populations
widespread.
Who Uses the MMSE?
The Professionals Who Use It
Many different professionals use the test. Most primary care
physicians believe that cognitive and/or dementia screening
is important but that time constraints often prevent it.11-15 The
MMSE has been recommended as a dementia screen by both
the US Preventive Services Task Force and in a report by the
American Academy of Neurology16,17 among others. The
National Institute of Health and Clinical Excellence18 use
MMSE cutoffs to determine Alzheimer Disease (AD) treatment
eligibility.
Populations It Has Been Used in
Originally intended to be used with psychogeriatric
patients,1,19 the test has been used in diverse populations
including those with a variety of neurological disorders.
Dementia. The MMSE has been most often used to assess
dementia1,8,20 an obvious development considering the fact that
it was designed as a cognitive screen for the older population
and the incidence of dementia typically increases with age.
While the Diagnostic and Statistical Manual of Mental Disor-
ders (DSM)21 criteria for a dementia diagnosis focus on mem-
ory loss in the early stages, there are many different types of
dementia and memory problems may/may not be the first
‘‘sign.’’ The question is whether the MMSE can discriminate
between the dementias.
Due to the fact that the MMSE is memory- and language-
oriented, it has a bias toward temporal and parietal lobe func-
tioning22 and as such should be more sensitive in patients with
degeneration and/or lesions in these areas. Indeed, patients with
AD have been found to perform more poorly than other demen-
ted patients on the items ‘‘recall of 3 words’’ and ‘‘orientation
to time’’ while those with vascular dementia did more poorly
on items of attention.23 However, Brown et al22 found that the
MMSE could only detect a low 52% of their patients with AD.
Furthermore, frontal patients typically suffer more from prob-
lems with executive functioning (EF), an aspect of cognition
that is underrepresented in the test. Indeed, the MMSE has been
found to be poorly sensitive to frontal lobe dysfunction and
those with frontotemporal dementia have typically higher total
scores and a slower decline than is the case in other forms of
dementia.24 The MMSE may therefore not be the best instru-
ment to use if clinicians want to determine dementia type.
Parkinson disease dementia (PDD). The MMSE has also been
used to detect dementia in the Parkinson population.25 Zadikoff
et al26 concluded that the test lacks sensitivity in early
PDD. This is perhaps not surprising given the finding that
it also lacks sensitivity in differentiating between mild
cognitive impairment (MCI) and the early stages of any form
of dementia.8
Delirium. Arsène and Lassaunière27 compared the MMSE
with the Blessed Orientation-Memory-Concentration test
(BOMC) in delirious patients who also had cancer and found
the BOMC to be better for screening delirium in these patients.
McManus et al28 found a strong correlation between MMSE
scores less than 10 and delirium in patients who had just suf-
fered a stroke and concluded that low scores may enhance the
identification of patients at risk of delirium in the stroke popu-
lation. Improvements in MMSE scores may be observed in the
short term after a delirious episode has abated, but this may not
hold over the long term.29 The fluctuating nature of delirious
episodes makes it particularly difficult to test these patients
while such episodes have also been linked with poorer long-
term (tested at 12-month follow-up) memory even in those
without underlying dementia.30 O’Keeffe et al31 found, how-
ever, that abrupt declines and improvements in serial MMSE
scores could be useful when monitoring the development and
resolution of delirium respectively in a population of elderly
hospital patients.
Depression. The MMSE has been used to assess cognitive
functioning in patients with various mood disorders. The prob-
lem is how to interpret the scores. Low scores could mean cog-
nitive impairment and possible comorbidity with dementia or
simply that patients are not motivated to perform well on the
test (as a function of their underlying mood state). The MMSE
has however been usefully employed to monitor cognitive
change over time and pharmacological treatment in patients
with clinical depression.32
Stroke. The MMSE is routinely used in stroke assessment.
Studies show, however, that it may only be adequate in detect-
ing cognitive impairment in left- but not right-hemispheric
stroke33 especially if the extended version (the 3MS2) is used.
Grace et al33 also found that the test misclassifies those with
aphasia, a common problem in stroke, as it is chiefly language
dependent. Nys et al34 found that the accuracy of detecting cog-
nitive impairment with the MMSE in acute stroke was no better
than chance and could find no optimum cutoff score that they
could use in this population. These authors concluded that the
test was insensitive to impairments in EF, abstract reasoning,
and visual perception/construction, all of which are often
impaired in the early stages after a stroke.
Multiple sclerosis (MS). Beatty and Goodkin35 reviewed the
use of the test in patients with MS. Their conclusion was
that it is not sensitive enough to identify (diagnosed) dementia
in these patients but that it can still be useful as a predictor of
focal cognitive impairments in (mildly physically disabled)
relapsing-remitting patients.
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General Medical Populations
Cukierman et al36 used the MMSE to assess cognitive change in
diabetic patients but found that it had limited ability to detect
changes in attention and processing speed and therefore ques-
tioned how useful it was in this population. The test has also
been used to assess cognitive change in a wide variety of patients
with cancer, but again its use has been questioned here.29
Settings It Has Been Used in
The MMSE has been used in a wide variety of settings over the
years, but whether setting influences the scores obtained has
not been comprehensively analyzed, at least until recently.
Mitchell8 identified 3 chief settings where the test has been
used: memory clinics, mixed specialist hospitals, and nonclinic
community settings. The case-finding ability of the test was
found to be best in specialist settings and the least successful
in memory clinics. The differences were however relatively
small and could be arguably attributed to ceiling effects.
Considering the fact that memory clinics may be the first
‘‘port-of-call’’ for older people concerned about their memory
this finding deserves more research attention.
Advantages and Disadvantages of the MMSE
The MMSE has retained its popularity over the years suggest-
ing that it has its advantages as a cognitive screening instru-
ment. However, for every advantage a disadvantage can also
be named. A list of the pros and cons of the test can be found
in Table 1.
1) International use, translations of the MMSE. While the
test is internationally used, the question remains as to
whether the translations are always true to the original
intentions of Folstein et al.1 The literature37 suggests
that some words and phrases are not easily translated
(eg, ‘‘no ifs, ands, or buts’’) and some of the concepts
may not be relevant to people from other, non-English
speaking cultures (eg, spell WORLD backward). Cau-
tion should therefore be used when interpreting MMSE
scores in different countries.
2) Tester/clinician characteristics. The test can be admi-
nistered by experts and nonexperts alike and is widely
taught in many higher education establishments. Many
researchers believe that scoring should not fluctuate
widely between testers but there are some indications23
that interrater reliability is not stable suggesting that
the test may be administered and/or scored differently
by different testers.
3) Comparison between studies: the use of standard cutoff
scores. One of the most often quoted advantages of the
MMSE is that it makes comparison between studies pos-
sible and as such is often used in the inclusion/exclusion
criteria in research. The problem is that different cutoff
scores have been used and it is difficult to know which
are the best to use when assigning patients into groups
for comparison. A cutoff of 23 or less with 8 years or
more of education has generally been taken as evidence
of cognitive impairment.38 However, some authors35,39-
41 suggest that this relatively low cutoff needs to be
raised to improve the test’s sensitivity and specificity,
while still others say it needs to be lowered to identify
more cognitive impairment.42 Which cutoff one uses
will obviously have an impact not only on participant
inclusion in research but also on whether a person is
labeled as having cognitive impairments or not.
4) Total scores versus item analysis. A related question as
to which cutoff is the best one is the issue of using a sin-
gle, total score to measure cognitive impairment. This
has its advantages in that it is a kind of barometer or
objective measure of cognitive ability that can easily
be compared across studies and populations. While Fol-
stein et al1 suggested that there were 11 categories cov-
ered in the MMSE, Tombaugh and McIntyre7 said that
Table 1. The Advantages and Disadvantages of the MMSE
Pros Cons
1. Internationally used and widely translated Translations not always good. Scores in other cultures may not be reliable
2. Can be administered by experts and nonexperts Interrater reliability may be unstable. Testers & settings can influence scores
3. Comparison between studies possible Heavy reliance on total scores while differing cutoff scores are used
4. Use of a single, total score to measure cognitive
impairment
Item and pattern analysis might be the way forward but requires more time & effort
5. Measures general cognitive ability Heavy reliance on language and memory but not EF makes its use for differential
diagnostics limited
6. Norms (age and education) available More variables than just age and education affect scores and norms not always available
in all countries
7. Total maximum score ¼ 30 making scoring quick
and easy
Score range limited. Floor and ceiling effects common
8. Psychometric properties of the MMSE believed to
be good
Not all studies find stable interrater reliability
9. Quick to administer/portable Not quick enough for General Practioners (* 10 minutes)




the items could be grouped into 7 cognitive domains.
Lopez et al42 carried out a factor analysis and found 3
main factors (Orientation, Language, and Attention and
Calculation), while others have suggested 5 factors.43-46
The point here is that the MMSE is not unidimen-
sional,42 which a total score seems to suggest. Further-
more, Ramirez et al10 found using a differential item
functioning (DIF) analysis that different items per-
formed differently for different groups tested. Lopez
et al42 agreed many items were classified as ‘‘too easy’’
in their item analysis. Focusing on how points are won
and lost may therefore provide more information about
a patient than their total score.
5) General versus specific cognitive assessment. The test
was initially developed as a screen to detect general
cognitive impairment and not, as it has become, a diag-
nostic tool, which implies assessment of specific cogni-
tive domains. Indeed, the MMSE has been criticized for
its heavy reliance on verbal tests,42 especially those con-
cerned with orientation (total of 10 points) and language
(total of 9 points), a problem when using the test in those
with poor language skills and/or low education. Ulti-
mately, the test may be more useful in measuring the
severity of cognitive problems as it is less able to discri-
minate between healthy older people, those with MCI,
and those suffering from early dementia.8
6 &7) Norms for age and education and other variables that
can affect scores. MMSE total scores are sensitive to
education, age, race, socioeconomic status and culture
among other variables.23 In addition, gender may or
may not influence scores.37 Generally, as age increases
total score decreases and 12% of the variance of MMSE
scores has been attributed to age and education alone.47
Lower scores are also found for those with lower educa-
tion and lower socioeconomic status. As a result of
these studies, age- and education-based norms have
been proposed48 and indeed the test (since 1993) comes
with the Crum norms attached. Jones and Gallo45 ques-
tion the usefulness of these norms, however, due to the
fact that the original sample sizes used to formulate the
values were low—less than 100 and as small as 17.
Other researchers have found that these norms may not
actually be routinely used by either clinicians or
researchers.47,49,50 Those with a high level of education
tend to do well on the MMSE despite impending
dementia (the cognitive reserve hypothesis may explain
this phenomenon51). Le Carret et al52 found that those
with higher education tend to have more problems with
abstract thinking in the early stages of dementia
whereas those with less education tend to do more
poorly on memory and attention tests. As the MMSE
focuses on the latter 2 cognitive domains and does not
address abstract thinking, it may bias the results in favor
of those with more education.52 Indeed, although rare,
individuals can score 30/30 on the MMSE and still have
been just diagnosed with early-stage dementia.53
Other factors that might influence scores include vision and
hearing impairment, anxiety, depression, musculoskeletal disor-
ders, dysarthria and dysphasia10,23 and the effects of medication
on scores should be considered. For example, cholinesterase
inhibitors, used widely in the treatment of early AD, have been
found in at least 1 study to stabilize MMSE scores (see 54 for a
review). Ceiling and floor effects are common with the test.8
8) Psychometric properties of the MMSE. Internal consistency
and test–retest reliability (0.80 to 0.957) are generally good
while interrater reliability is variable. Reliability tends to be
high but can drop with repeated testing and seems to
depend on when the retesting is carried out (it seems to
be better if the period between baseline and follow-up is
short42 or at 1 year55). The validity for a cutoff score of
24 has been quoted to be 87% for sensitivity and 82%
for specificity.50 According to Mitchell,8 there have been
70 MMSE validation studies conducted to date but most are
underpowered giving a misleading impression of accuracy.
Possible learning/practice effects have also been found
throughout the literature and indeed patients may talk to
each other and discuss tests they have been given.53 They
may also be more likely than was the case in the past to
attempt to self-diagnose: there is nothing stopping individ-
uals from self-testing online. Clinicians can change the
words for the recall item, but there are no parallel forms for
other components of the test. Recently, Mitchell8 stated
that at the very least specificity, sensitivity, positive likeli-
hood ratio (LR), and negative LR should be calculated for
tests that claim to be cognitive screens. Cherbuin et al56
added misclassification rate to this list and gave this to
be 15% for the MMSE.
9) Ease of administration. A selling point for the MMSE has
always been its portability: the fact that all that is needed is
paper and pencil and the clinician can test a patient at their
bedside. This and the fact that it is relatively quick to
administer (<10 minutes) make it a favorite among many
testers. General practitioners are, however, less enthusias-
tic. In a recent survey conducted in the United Kingdom,
Milne et al57 found that the average doctor’s consultation
there lasts just 7.5 minutes, while Deveugele et al58 stated
that the average length of a consultation in Europe was
10.7 minutes. The MMSE (10 minutes to complete) is
therefore not as widely used among general practitioners
as it is assumed to be.57
10) Availability vs copyright. The test has been placed under
copyright since 2001, a fact that few users are aware of.59
This entails paying a fee ($1 per test) every time it is
administered in its entirety, making it too costly and pro-
hibitive for many. Martin and O’Neill59 have called for
the removal of the copyright fees.
Discussion
The MMSE remains the most used test for dementia screening
and is regularly used in research as a benchmark for severity of
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dementia.60 The question as to whether it should stay in this
position is addressed in this review. Few cognitive screening
instruments have had such a successful history and as wide-
spread acceptance as the MMSE. This popularity could be due
to a number of things including: its relative brevity, its portabil-
ity, its focus on cognitive status as a single total score (making
it easy for people to understand and compare), its possible abil-
ity to track decline over time, that you do not need to be an
expert to administer it, and ultimately due to the real need for
quick cognitive assessment, especially in an aging world where
limiting assessment duration is often a priority. Cutoff scores
are also easier to interpret than differing patterns of cognitive
dysfunction which item analysis can highlight but which
requires more effort/work/time to achieve, and time is some-
thing doctors and other professionals do not have. Many users
of the MMSE are, however, becoming more aware of the need
to pay attention to how points are lost on the test and in turn to
focus less on total scores.53
Accurate detection of early stage dementia is crucial as
treatments begin to evolve (currently, only those able to slow
down progressive disease are available23,61). A cognitive
screen that is used as a first step in dementia diagnosis
clearly needs to perform well in those with early dementia. This
ability to differentially diagnose, especially in the early stages
of dementia, is one of the major difficulties of the MMSE
and calls into question its usefulness as a diagnostic tool.8 Age
and education are not the only variables which can affect test
scores: race, socioeconomic status and (some researchers find
gender53,37) can also affect scores making translated MMSEs
difficult to interpret in heterogeneous, culturally diverse popu-
lations53 Despite these flaws, the test has been used to quantify
the severity of cognitive impairment while it clearly suffers
from ceiling effects, especially in the highly educated.
A central question addressed at the beginning of this review
was: Does the MMSE fulfill its original purpose? To recap, the
MMSE had 3 main original aims: to screen for cognitive
impairment in elderly patients under psychiatric care; to assess
the severity of cognitive impairment; and to monitor change via
serial testing. The question is: has it fulfilled these aims? The
short answer has to be yes, the MMSE has fulfilled its original
purpose, certainly in the early years (1970s-1980s). However,
as with many tools, its weaknesses have since been exposed
and competitors developed. The test may still be useful in cer-
tain circumstances with the caveat that monitoring change may
be more problematic than was originally thought (practice
effects, patients studying the test, low interrater scores, differ-
ing medications, comorbidities, life events, settings and more
have all been shown to affect follow-up scores62). While the
MMSE may not have completely outlived its usefulness, other
short cognitive screens (for recent reviews see 63,64) should be
comprehensively and systematically assessed over a variety of
populations and settings instead of simply relying on the
MMSE to screen (mainly verbal aspects of) cognition.
This review has also highlighted the fact that clinicians and
researchers may place too much emphasis on MMSE cutoff
scores and focus not enough on which items are passed and
failed. While a total score on any screen (not just the MMSE)
may be taken as a first indication that something is wrong, it
may hide too much about what the person can or cannot do. The
focus should therefore be on what mistakes are made followed
up with much more detailed assessment. The MMSE still has
its uses and should be considered before adopting a new, per-
haps untested, screening instrument. Above all, a diagnosis
of dementia should not rely chiefly on a MMSE total score. The
focus should be on the individual, their history, their strengths,
and weaknesses. Only then will clinicians be able to understand
and hopefully assist patients in the way these older people
deserve to be treated.
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